-

Empower Community Care Invests in The Incredible Years®

ATLANTA--(BUSINESS WIRE)--Empower Community Care (“Empower”), a leading global behavioral health organization responsible for distributing evidence-based programs and technologies, is pleased to announce it has acquired The Incredible Years®, Inc. (“Incredible Years”). Incredible Years provides a series of evidence-based programs for parents, children, and teachers that aim to prevent and treat young children’s behavior problems and promote their social, emotional, and academic competence. Empower’s existing investors include its management team and Northlane Capital Partners (“NCP”).

Led by Dr. Carolyn Webster-Stratton MS, MPH, PhD and supported by over 40 years of research and multiple randomized control trials, the Incredible Years’ programs and models are used worldwide across multiple languages and cultures in schools, childcare settings, mental health centers, and hospitals. Dr. Webster-Stratton will continue with Incredible Years following the transaction.

“Our partnership with Incredible Years represents an exciting opportunity for Empower and enables us to better serve youth and families. Incredible Years will operate independently under the Empower platform. We intend to enhance its breadth of products and services through additional investment that will help further expand access to the Incredible Years model,” said Keller Strother, Co-Founder of Empower.

Dr. Webster-Stratton noted, “We are very excited about this new opportunity for Incredible Years and the ability for Empower to support the continued growth of the Incredible Years program. Our commitment to quality and service will not change, and we are confident the partnership with Empower will enable us to better serve our partners.”

ABOUT EMPOWER COMMUNITY CARE

Empower is the leading global behavioral health organization responsible for distributing evidence-based programs and technologies. With approximately 100 employees serving more than 1,200 customers across 50 U.S. states and 19 countries, Empower’s mission is to transform the lives of troubled youth, adults, their families and communities. Our companies use scientifically proven treatments, approaches, and tools to improve services and care available to vulnerable populations. Additional information is available at www.empowercommunitycare.com.

ABOUT NORTHLANE CAPITAL PARTNERS

Based in Bethesda, MD, NCP is a middle market private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested more than $1.6 billion of equity capital. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. For more information, please visit www.northlanecapital.com.

Contacts

EMPOWER CONTACTS

Josh Glade, CEO
(843) 352-4473

Keller Strother, Co-Founder, Empower
(843) 352-4691

NCP CONTACTS

Eugene Krichevsky, Partner
(301) 841-1399

Scott Kauffman, Partner
(301) 968-9227

Charles Donahue, Vice President
(301) 272-9991

Empower Community Care


Release Versions

Contacts

EMPOWER CONTACTS

Josh Glade, CEO
(843) 352-4473

Keller Strother, Co-Founder, Empower
(843) 352-4691

NCP CONTACTS

Eugene Krichevsky, Partner
(301) 841-1399

Scott Kauffman, Partner
(301) 968-9227

Charles Donahue, Vice President
(301) 272-9991

More News From Empower Community Care

Northlane Capital Partners Announces Investment in Plus Delta Partners

CARLSBAD, Calif.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has made an investment in Plus Delta Partners (“PDP”), a leading provider of specialized fundraising training and tools designed to enable higher education institutions, healthcare organizations, and other nonprofits to maximize donor contributions. NCP invested alongside PDP’s management team and its founder, Guy Hart. PDP offers a comprehensive suite of fundraising training solutions tailored to fron...

Northlane Capital Partners Invests in United States Drug Testing Laboratories

DES PLAINES, Ill.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has invested in United States Drug Testing Laboratories Inc. (“USDTL”), a forensic toxicology laboratory testing for alcohol and substance use. NCP invested alongside USDTL’s management team and its founders, Veronica and Doug Lewis. USDTL is headquartered in Des Plaines, IL, and offers a broad suite of forensic testing capabilities. The company primarily serves hospitals, health systems, court system...

SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired IDEA Pharma (“IDEA”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. IDEA, headquartered in London, United Kingdom, specializes in pharmaceutical path-to-market strategy and innovation. This acquisition strengthens SAI’s ca...
Back to Newsroom